|
Xanthomatosis, Cerebrotendinous
|
D019294 |
[An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.
] |
|
Insulin-Like Growth Factor I
|
D12.776.467.937.400 |
|
|
Somatomedins
|
D12.776.467.937 |
|
|
Arsenic Poisoning
|
D020261 |
[Disorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)
] |
|
Computational Biology
|
D019295 |
[A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets.
] |
|
Capnography
|
D019296 |
[Continuous recording of the carbon dioxide content of expired air.
] |
|
Megestrol Acetate
|
D019290 |
[Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
] |
|
Mean Platelet Volume
|
E01.370.225.625.625.392 |
|
|
Pentalogy of Cantrell
|
C16.131.666.680.705 |
|
|
Skull Base
|
D019291 |
[The inferior region of the skull consisting of an internal (cerebral), and an external (basilar) surface.
] |
|
Skull Base Neoplasms
|
D019292 |
[Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull (SKULL NEOPLASMS).
] |
|
Alcohol-Induced Disorders, Nervous System
|
D020268 |
[Acute and chronic neurologic disorders associated with the various neurologic effects of ETHANOL. Primary sites of injury include the brain and peripheral nerves.
] |
|
Alcoholic Neuropathy
|
D020269 |
[A condition where damage to the peripheral nervous system (including the peripheral elements of the autonomic nervous system) is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. (From Arch Neurol 1995;52(1):45-51; Adams et al., Principles of Neurology, 6th ed, p1146)
] |
|
Penaeidae
|
B01.050.500.131.365.190.660 |
|
|
Radiotherapy, Conformal
|
D020266 |
[A therapy using IONIZING RADIATION where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators.
] |
|
MPTP Poisoning
|
D020267 |
[A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8)
] |
|
Opiate Substitution Treatment
|
D058850 |
[Medication-assisted treatment of opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.
, Opiate substitution treatment combined with COUNSELING; BEHAVIOR THERAPY and/or support services.
] |
|
GPI-Linked Proteins
|
D058851 |
[A subclass of lipid-linked proteins that contain a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE which holds them to the CELL MEMBRANE.
] |
|
Leukotriene E4
|
D23.469.050.175.450.725.425 |
|
|
Dual-Specificity Phosphatases
|
D08.811.277.352.650.625.225 |
|
